Mary Lou Jepsen’s Post

View profile for Mary Lou Jepsen

Chairman & Founder of Openwater, Previously co-founder of OLPC, exec at Google, FB, Oculus & Intel

Just watched Larry Ellison talk about #StargateProject as healthcare R&D - but is not talking actual costs per person if the R&D for their therapies are successful. When you spend $500B as a group of corps. you expect to make money with that invest. We need to frame discussion around how.. not later.. but when we start the project. Today's new drug therapies are now over $1M per dose because of the couple of billion $ spent on each regulatory approval. It sounds like more of the same and I assume the NGOs and Governments will pour in financial support as well... but never discuss the cost of the outcomes: More $1M therapies that the vast majority of humanity can't afford. An alternative approach - Open Source and general purpose devices. Example: http://Openwater.health offers low cost treatments for a range of #cancer s, #mentaldisease, #neurodegenerative disease and #cardiovascular disease in pre-clinical and clinical development now. Fully #Opensource, always: Where the devices at scale will be the price of a smartphone and the treatments can reach the cost of a phone call. No drugs needed nor shortages. General purposes devices using ultrasound levels and infrared light levels show safe for 100 years on billions of people and the consumer electronics supply chain.

  • timeline
S V.

Innovator, space thruster engine.

2mo

Completely agreed on this!

Like
Reply
David Hakala, Ph.D.

Consultant to the Electronics Industry: Manufacturing/Product Development/Quality Expertise

2mo

Not into this a fraction of what you are obviously but I sincerely hope you succeed

Like
Reply

Completely agree that high cost of therapies limits access to patients who need it the most, and in some cases completely excludes small patient populations. We're also hoping that open source medical devices can reduce costs and expand therapeutic access, and proud to help contribute to the field through our OpenNerve platform.

Kirsten Jarvi, MS

Chief Executive Officer at APstrategists Driving Business Transformation-boards | Empowering Healthcare Innovation| Championing Transformational Leadership| Advancing Health & Athletics

2mo

There is a better way. As discussed last year in San Francisco & Santa Monica. We have the solution. I believe it’s in the open source stack using the two Journal’s. Will explain probably better by video. KISS strategy. And the reverse bioengineering discussion from last week. 100% Jepsen

Like
Reply
Lucien Engelen

Health(care) strategy & digital transformation Maven. International Ambassador Nursing Innovation. (im)Patient. International keynote speaker. Makes things happen.

1mo
Like
Reply
Dr Christina Maher

Neuroscientist + biomedical engineer | Making healthcare accessible | Ex @Macquarie Bank | PhD in AI and neuroscience

2mo

Open source is the way to go

Like
Reply

i caught his remarks as well Mary Lou and wondered, how will people afford it? who pays? especially the ones who need it most.

Like
Reply
Vinod Lakhani

In stealth mode - working on something exciting

2mo

Well said. Open source has enabled a lot of innovation in the infrastructure space. Great to see those principles being applied to the Life Sciences segment.

Richard Morgan

Modern Healthspan: Empowering you to live a longer, healthier, more fulfilling life

2mo

Yes! As long as the current system exists (enormous up front costs, long lead time) we will end up with expensive, specific therapies. My concern is to slow or reverse aging (which will in turn improve many [all?] of the chronic diseases). The Openwater approach is much more likely to help here than a patented intervention which needs to recoup 500B in investment!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics